Table 3 Subgroup analysis.

From: Triglyceride-glucose index and hsCRP-to-albumin ratio as predictors of major adverse cardiovascular events in STEMI patients with hypertension

 

TyG index < 7.8

TyG index ≥ 7.8

P for trend

hsCAR < 0.15 n = 204

hsCAR ≥ 0.15 n = 267

hsCAR < 0.15 n = 81

hsCAR ≥ 0.15 n = 147

Age < 65

Yes

Ref.

1.75 (0.97–3.15)

1.63 (0.83,3.20)

3.21 (1.80–5.72)***

< 0.001

No

Ref.

1.26 (0.82–1.95)

2.69 (1.46,4.94)**

3.00 (1.78–5.06)***

< 0.001

Male

Yes

Ref.

1.37 (0.92–2.04)

1.52 (0.89,2.58)

3.05 (1.96–4.75)***

< 0.001

No

Ref.

1.47 (0.72–3.01)

4.58 (1.87,11.24)**

2.74 (1.21–6.21)*

0.007

Diabetes

Yes

Ref.

1.16 (0.61–2.22)

1.56 (0.76,3.21)

1.72 (0.90–3.31)

0.06

No

Ref.

1.43 (0.95–2.15)

2.32 (1.30,4.15)**

3.98 (2.46–6.43)***

< 0.001

SYNTAX Score < 22

Yes

Ref.

2.19 (1.32–3.65)**

3.12 (1.70,5.73)***

4.55 (2.62–7.88)***

< 0.001

No

Ref.

0.77 (0.48–1.24)

0.94 (0.46,1.93)

1.71 (0.97–3.01)

0.025

PCSK9i

Yes

Ref.

0.21 (0.05–0.80)*

2.10 (0.62,7.09)

2.65 (0.79–8.87)

0.013

No

Ref.

1.56 (1.08–2.27)*

1.78 (1.09,2.93)*

3.04 (2.02–4.59)***

< 0.001

SGLT2i

Yes

Ref.

2.05 (0.81–5.17)

1.22 (0.40,3.71)

1.52 (0.58-4.00)

0.22

No

Ref.

1.25 (0.86–1.83)

2.10 (1.27,3.47)**

3.47 (2.26–5.33)***

< 0.001

  1. hsCAR: high-sensitivity C-reactive protein-to-albumin ratio; PCSK9i: proprotein convertase subtilisin/kexin type 9 inhibitor; SGLT2i: sodium–glucose cotransporter 2 inhibitor. * denotes P < 0.05, ** denotes P < 0.01, and *** denotes P < 0.001.
Back to article page